- Home
- TSI vs OSUR Comparison
TSI vs OSUR Comparison
Compare TSI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSI
- OSUR
- Stock Information
- Founded
- TSI 1987
- OSUR 2000
- Country
- TSI United States
- OSUR United States
- Employees
- TSI N/A
- OSUR N/A
- Industry
- TSI Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- TSI Finance
- OSUR Health Care
- Exchange
- TSI Nasdaq
- OSUR Nasdaq
- Market Cap
- TSI 234.6M
- OSUR 223.0M
- IPO Year
- TSI N/A
- OSUR 1986
- Fundamental
- Price
- TSI $4.90
- OSUR $3.00
- Analyst Decision
- TSI
- OSUR Hold
- Analyst Count
- TSI 0
- OSUR 1
- Target Price
- TSI N/A
- OSUR $3.00
- AVG Volume (30 Days)
- TSI 106.8K
- OSUR 804.6K
- Earning Date
- TSI 01-01-0001
- OSUR 08-05-2025
- Dividend Yield
- TSI 7.46%
- OSUR N/A
- EPS Growth
- TSI N/A
- OSUR N/A
- EPS
- TSI N/A
- OSUR N/A
- Revenue
- TSI N/A
- OSUR $161,626,000.00
- Revenue This Year
- TSI N/A
- OSUR N/A
- Revenue Next Year
- TSI N/A
- OSUR $6.20
- P/E Ratio
- TSI N/A
- OSUR N/A
- Revenue Growth
- TSI N/A
- OSUR N/A
- 52 Week Low
- TSI $4.48
- OSUR $2.36
- 52 Week High
- TSI $4.87
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- TSI 29.71
- OSUR 54.60
- Support Level
- TSI $4.90
- OSUR $2.78
- Resistance Level
- TSI $4.94
- OSUR $3.03
- Average True Range (ATR)
- TSI 0.04
- OSUR 0.13
- MACD
- TSI -0.01
- OSUR 0.01
- Stochastic Oscillator
- TSI 0.00
- OSUR 58.93
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.